common issue associated with morbidity, mortality and substantial healthcare costs. [2] [3] [4] Postoperative delirium is defined as a disturbance in attention and awareness developing over a short period of time (acute change from baseline), which tends to fluctuate in severity during the course of the day and can present with an additional disturbance in cognition (such as memory deficit, disorientation, language, visuospatial ability or perception). 5 In patients over 60 years of age undergoing major surgery, the incidence of postoperative delirium has been suggested to fluctuate between 26% and 46%. [6] [7] [8] [9] [10] While delirium responds to well-characterised criteria, postoperative cognitive dysfunction (POCD) remains an ill-defined entity: occurring days to weeks after surgery, POCD is a chronic condition which manifests itself as a subtle decline in cognitive function (eg memory deficit), usually detected with neuropsychological tests. [11] [12] [13] Ketamine is a widely used anaesthetic drug with hypnotic and analgesic properties. 14 Acting as an N-methyl-D-aspartate antagonist, ketamine has been found to exhibit neuroprotective effects in a variety of laboratory experiments, mainly through its potential to reduce apoptosis, inflammation or microthrombosis. 15 In the clinical setting, evidence of a neuroprotective effect originates mainly from paediatric studies, where the intraoperative administration of ketamine significantly reduces the rate of emergence agitation. 16 Over the years, an increasing number of studies examining the effects of ketamine on cognitive outcomes in the adult population have been published, but, to date, no consensus seems to exist. Therefore, the aim of this systematic review was to evaluate the effects of ketamine administered during general anaesthesia on the occurrence of postoperative delirium and POCD. We assumed that ketamine would reduce the risk of neurocognitive complications. We were also interested in assessing whether ketamine, when administrated with the intent to prevent neurocognitive complications, would increase the risk of adverse events (AE) (non-cognitive outcomes, including mortality) or prolonged length of stay (post-anaesthesia care unit [PACU] , ICU or hospital stay). Finally we planned to explore the effect of age, specific anaesthesia regimen (inhalational vs intravenous anaesthesia), depth of anaesthesia and hemodynamic events through subgroup analyses.
| ME TH ODS
We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines for the reporting of systematic reviews. 17 The quality of the evidence was assessed using the GRADE approach 18 and recommendations from the Cochrane Collaboration. 19 Eligibility criteria, outcomes and statistical methods were predefined (study protocol registered on PROSPERO-CRD42017057016).
| Eligibility criteria
Only randomised controlled trials (RCTs) were considered. Whenever data were available as abstract only, authors were contacted for further clarification. If data were reported in several reports (duplicates) or in subgroup analyses of larger RCTs, the first published article was considered the main article. 20 We considered trials performed in adult patients (≥18 years old)
undergoing any type of surgical procedure under general anaesthesia. Trials investigating ketamine for sedation or pain control were excluded.
We searched for trials comparing the intraoperative administration of ketamine versus no intervention (no drug or placebo). No restriction regarding doses, administration schema or duration was applied. Trials not adequately controlled (eg using another drug as comparator) were excluded.
We were interested in identifying the effects of ketamine on cognitive outcomes. Thus, we searched for trials reporting on postoperative delirium or POCD (primary outcomes). No restriction regarding outcome definition or measurement was applied. The following endpoints were considered as secondary outcomes: noncognitive AE, mortality and length of stay (PACU, ICU or hospital stay).
| Data sources and searches
We searched for relevant reports in the Medline (Ovid), Embase and Cochrane Central databases using MeSH terms and keywords com- Potentially relevant articles published in foreign languages were translated and assessed for eligibility. The last electronic search was done on 4 March 2018.
| Study selection
Titles and abstracts were screened by two independent reviewers (FH, CT) and potentially relevant reports assessed for eligibility. Duplicate publications were identified through comparison of reports for shared author names, enrolment date, setting, intervention, number of participants or baseline data. Disagreements were resolved through discussion between the two reviewers.
Editorial Comment
In this systematic review and meta-analysis, the authors found low quantity and quality of evidence that ketamine prevents delirium and postoperative cognitive dysfunction. 
| Risk of bias in individual studies
The risk of bias was assessed using the Cochrane "Risk of bias" tool, which covers selection bias, performance bias, detection, attrition bias, reporting bias and other sources of bias (see items description in supplementary material 3). The effects of detection and attrition bias were specifically explored, since this may affect studies evaluating AE. 
| Grading quality of the evidence
The quality of evidence was assessed using the GRADE approach.
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Factors such as high likelihood of methodological bias, unexplained heterogeneity, inconsistency or imprecision of results were deemed to decrease the quality level of a body of evidence. The following ratings were used: high, moderate, low, very low.
| Synthesis of results
Dichotomous outcomes were reported as risk ratios with 95% confidence intervals (CI), while continuous data were expressed as weighted mean differences with 95% CI. Data handling and transformation were not necessary.
| Data synthesis and analysis
We used primarily the Mantel-Haenszel method, since other models (such as the inverse-variance method) which do not account for low event rates and small study sizes, have been found to introduce bias. 19, 22 A P-value <.05 and 95% CI not crossing the equality line were considered statistically significant. Sources of clinical heterogeneity were all pre-specified. Because we expected substantial clinical and methodological heterogeneity, we used a random effects model. 23 Data were summarised using a qualitative assessment when statistical combination was deemed inappropriate.
| Additional analyses
Where the data allowed, we planned to explore the effect of age, specific anaesthesia regimen (inhalational versus intravenous anaesthesia), depth of anaesthesia and intraoperative hemodynamic events through pre-defined subgroup analyses, since these factors have been found to affect the occurrence of postoperative cognitive outcomes. 1, 25, 26 We performed sensitivity analyses using Peto odds ratio method, which has been suggested to perform well with rare events. 41, 42 Thus, data from 6 RCTs (n = 928 patients) were considered for analysis.
| Study characteristics

| Study design, setting and participants
Included trials were published between 2008 and 2017 (Table 1) .
Five were reported in the English language, while 1 was in Chinese. 45 A 2-arm parallel design was used in all trials except in 2.
39,40
Apart from one recently published trial, sample sizes were small. The authors of three trials were contacted for data clarification, 38, 39, 44 two responded to our inquiry. 39, 40 All trials were performed in a major surgery setting except one conducted in a mixed setting (major and minor orthopaedic procedures). 43 Surgical settings and surgery duration varied across trials.
All trials included participants with mean age >60 years except 
| Intervention characteristics
In most included trials, intravenous ketamine was compared to the administration of a placebo (saline bolus or infusion) ( Table 2) . Various administration strategies were found across trials but in most, patients were administered a single bolus of ketamine (0.5 mg kg
À1
) at the induction of anaesthesia. 38, 42, 43, 45 In both 3-arm parallel trials, 39, 40 intervention groups deemed the least comparable with other studies were not considered in the analysis.
| Risk of bias in included trials
The risk of selection bias was unclear in all trials except 1, where selection bias was deemed low (see figure and table, supplementary material 5). 44 The risk of performance bias was unclear in most included trials except in 1, where the control group did not receive any intervention (no placebo). 44 Outcome assessors were adequately blinded in four trials. 39, 42, 43, 45 All trials were at low risk of attrition bias (minimum: no attrition (two trials), 42, 45 maximum: 9% (1 trial) 43 ) and at low reporting bias, except 1 reporting outcome data in two separate publications. 41, 42 Overall, four trials were deemed at low risk of bias.
39,40,43,45
| Results of individual trials and data syntheses 3.4.1 | Postoperative delirium
Postoperative delirium was reported in 4 trials (Table 3) . 39, 40, 42, 44 Outcome assessment was performed using the Confusion Assess- Figure 1) . Statistical (p = .11, I 2 = 51%) and clinical heterogeneity (ie variability in age, comorbidities and ketamine administration schema) were high. The quality of the evidence (GRADE assessment) was deemed low (Table 3) : 3 trials were at high or unclear risk of bias, outcome definitions differed across trials, substantial clinical heterogeneity was present and control event rates
were particularly low in 2 trials.
| Postoperative cognitive dysfunction
Three trials reported POCD (Table 3) . 41, 43, 45 Although all included trials used neurocognitive tests to determine the incidence of POCD, test batteries differed substantially across trials. Outcome assessment occurred relatively early in the recovery period (mostly 1 week postoperative). All trials used a similar method to detect POCD (postoperative decrease in neurocognitive performance), but in two, it remained unclear if a reference population was used to offset learning effects. 43, 45 When data were combined, patients receiving a single bolus of Table 3 ), the quality of the evidence was deemed very low.
| Secondary outcomes
Only one trial reported on non-cognitive AE: 39 GRADE Working Group grades of evidence High: We are very confident that the true effect lies close to that of the estimate of the effect. Moderate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. Low: the true effect may be substantially different from the estimate of the effect. Very low: the true effect is likely to be substantially different from the estimate of effect.
AF, atrial fibrillation; AKI, acute kidney injury; CAM, Confusion Assessment Method; CI, confidence interval; ICDSC, Intensive Care Delirium Screening Checklist; ICU, intensive care unit; MMSE, mini-mental status examination; POCD, postoperative cognitive dysfunction; RR, risk ratio; SD, standard deviation; WBC, white blood cells.
cardiac surgery study, length of stay (ICU and hospital stay) did not differ between groups (ICU stay: mean difference 0.00, 95% CI [À0.81, 0.81]; hospital stay: mean difference 1.00, 95% CI [À0.82,
2.82])
. 42 Since findings were based on very limited evidence, the quality of the evidence was deemed low (non-cognitive AEs, emergence-related adverse reactions), very low (length of stay) or not estimable (mortality) ( Table 3) .
| Additional analyses
Several factors potentially affecting the occurrence of postoperative neurocognitive outcomes were explored (Table 4 ). In most trials, patients received benzodiazepines preoperatively. All included trials used volatile anaesthetics for the maintenance of anaesthesia except 2: propofol was used in 1 trial, while there was no standardised In this study, patients in the ketamine group received concomitantly lidocaine 0.5 mg kg À1 bolus + 0.5 mg kg À1 h À1 intraoperatively.
Study or subgroup
Avidan 2017
Bornemann 2016 Hudetz 2009 Urban 2008 Total (95% CI)
Total events
Heterogeneity: τ² = 0.76; χ² = 6.10, df = 3 (P = .11); I² = 51%
Test for overall effect: Z = 0.30 (P = .76) We planned to perform subgroup analyses to explore the effect of these factors on neurocognitive outcomes, but the number of included trials was too small and data too heterogeneous to allow for meaningful statistical combination. 
47-51
Evidence of neuroprotection has also been described in the paediatric population, where the administration of ketamine decreased the risk of emergence agitation in a variety of surgical settings. [52] [53] [54] [55] [56] [57] [58] [59] These results, however, need to be interpreted with caution cardiac surgery only). [60] [61] [62] [63] Moreover, outcome definition and detection varied substantially across trials, which may have introduced further heterogeneity in the analyses. Finally, our ability to fully explore the safety of ketamine administration (non-cognitive AEs, mortality) or to perform additional analyses (effects of age, anaesthesia, hemodynamic events; effect of methodological heterogeneity) was hampered by the scarcity of data.
To date, this is the first systematic review to address the effects of intraoperative ketamine administration on neurocognitive outcomes. While our analysis provides a comprehensive summary of all currently available data on this important issue, it unquestionably pointed out evidence of relatively low quality and an important gap of knowledge regarding the safety of ketamine when administrated to prevent neurocognitive complications. Although the PODCAST trial 39 brought forth important insights on the effects of ketamine on postoperative delirium, other large well-designed RCTs (such as the POCK trial-NCT02892916) will be needed to confirm these results and clarify the effects of ketamine on POCD. We recommend that future trials target patients at high risk of neurocognitive complications and systematically collect intraoperative data (anaesthesia regimen and depth, hemodynamic events) and non-cognitive safety outcomes.
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